Search

Lakia J. Jackson-tongue

Examiner (ID: 14732, Phone: (571)272-2921 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645
Total Applications
886
Issued Applications
525
Pending Applications
104
Abandoned Applications
284

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18784777 [patent_doc_number] => 20230372409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => SOLID DOSAGE FORMS OF BACTERIA [patent_app_type] => utility [patent_app_number] => 18/027003 [patent_app_country] => US [patent_app_date] => 2021-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70376 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -116 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027003 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/027003
SOLID DOSAGE FORMS OF BACTERIA Sep 16, 2021 Pending
Array ( [id] => 18799973 [patent_doc_number] => 11833116 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-05 [patent_title] => Preparation method of yeast powder rich in nicotinamide mononucleotide, yeast powder, and methods for improving skin condition, hair health, antiinflammation, cardiovascular health, antioxidation, antiaging and/or relieving body fatigue [patent_app_type] => utility [patent_app_number] => 17/411067 [patent_app_country] => US [patent_app_date] => 2021-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 17004 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17411067 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/411067
Preparation method of yeast powder rich in nicotinamide mononucleotide, yeast powder, and methods for improving skin condition, hair health, antiinflammation, cardiovascular health, antioxidation, antiaging and/or relieving body fatigue Aug 24, 2021 Issued
Array ( [id] => 18923276 [patent_doc_number] => 20240026280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => PLASMID ADDICTION SYSTEMS [patent_app_type] => utility [patent_app_number] => 18/022895 [patent_app_country] => US [patent_app_date] => 2021-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25110 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -112 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022895 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022895
PLASMID ADDICTION SYSTEMS Aug 22, 2021 Pending
Array ( [id] => 17838893 [patent_doc_number] => 20220276198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => CHEMICAL SENSOR DEVICE AND CHEMICAL SENSOR MODULE [patent_app_type] => utility [patent_app_number] => 17/402220 [patent_app_country] => US [patent_app_date] => 2021-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2985 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17402220 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/402220
Chemical sensor device and chemical sensor module Aug 12, 2021 Issued
Array ( [id] => 17428405 [patent_doc_number] => 20220056113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => ANTI-O1 ANTIBODIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/397474 [patent_app_country] => US [patent_app_date] => 2021-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29190 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397474 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/397474
Anti-O1 antibodies and uses thereof Aug 8, 2021 Issued
Array ( [id] => 17593598 [patent_doc_number] => 20220143171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => CD40 LIGAND FUSION PROTEIN VACCINE [patent_app_type] => utility [patent_app_number] => 17/391103 [patent_app_country] => US [patent_app_date] => 2021-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23491 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391103 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/391103
CD40 LIGAND FUSION PROTEIN VACCINE Aug 1, 2021 Abandoned
Array ( [id] => 19563552 [patent_doc_number] => 12138303 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-12 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 17/389982 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 32 [patent_no_of_words] => 23121 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389982 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/389982
None Jul 29, 2021 Issued
Array ( [id] => 18938087 [patent_doc_number] => 20240033226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => CHITOSAN-Fe COATING-BASED SYNBIOTIC MICROCAPSULE WITH GASTRIC ACID RESISTANCE AND INTESTINAL TARGETED RELEASE AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 18/015193 [patent_app_country] => US [patent_app_date] => 2021-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015193 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015193
CHITOSAN-Fe COATING-BASED SYNBIOTIC MICROCAPSULE WITH GASTRIC ACID RESISTANCE AND INTESTINAL TARGETED RELEASE AND PREPARATION METHOD THEREOF Jul 22, 2021 Pending
Array ( [id] => 18583183 [patent_doc_number] => 20230265443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => REDUCTION OF FATTY ACID RETINYL ESTER FORMATION [patent_app_type] => utility [patent_app_number] => 18/017819 [patent_app_country] => US [patent_app_date] => 2021-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9218 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017819 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/017819
REDUCTION OF FATTY ACID RETINYL ESTER FORMATION Jul 21, 2021 Pending
Array ( [id] => 17355388 [patent_doc_number] => 20220016184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS [patent_app_type] => utility [patent_app_number] => 17/382426 [patent_app_country] => US [patent_app_date] => 2021-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15230 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17382426 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/382426
COMPOSITIONS COMPRISING BACTERIAL STRAINS Jul 21, 2021 Abandoned
Array ( [id] => 18626780 [patent_doc_number] => 20230285588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => SUPERANTIGEN CONJUGATE FOR USE IN METHODS AND COMPOSITIONS FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 18/006243 [patent_app_country] => US [patent_app_date] => 2021-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23855 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -62 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006243 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/006243
SUPERANTIGEN CONJUGATE FOR USE IN METHODS AND COMPOSITIONS FOR TREATING CANCER Jul 19, 2021 Pending
Array ( [id] => 19474084 [patent_doc_number] => 12104161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-01 [patent_title] => Production of soluble recombinant proteins without N-terminal methionine in [patent_app_type] => utility [patent_app_number] => 17/371449 [patent_app_country] => US [patent_app_date] => 2021-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10051 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371449 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/371449
Production of soluble recombinant proteins without N-terminal methionine in Jul 8, 2021 Issued
Array ( [id] => 17183835 [patent_doc_number] => 20210330720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => COMPOSITION AND METHODS FOR MICROBIOTA THERAPY [patent_app_type] => utility [patent_app_number] => 17/368494 [patent_app_country] => US [patent_app_date] => 2021-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15437 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368494 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/368494
Composition and methods for microbiota therapy Jul 5, 2021 Issued
Array ( [id] => 17183890 [patent_doc_number] => 20210330775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => VACCINE FOR PROTECTION AGAINST ETEC-INDUCED DIARRHEA COMPRISING DMLT [patent_app_type] => utility [patent_app_number] => 17/305236 [patent_app_country] => US [patent_app_date] => 2021-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7096 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305236 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/305236
Vaccine for protection against ETEC-induced diarrhea comprising dmLT Jun 30, 2021 Issued
Array ( [id] => 20592402 [patent_doc_number] => 12576098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-17 [patent_title] => Saponin containing extracts prepared from [patent_app_type] => utility [patent_app_number] => 18/011326 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4209 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011326 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/011326
Saponin containing extracts prepared from Jun 20, 2021 Issued
Array ( [id] => 17274454 [patent_doc_number] => 20210380652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE [patent_app_type] => utility [patent_app_number] => 17/346452 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20211 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346452 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/346452
Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use Jun 13, 2021 Issued
Array ( [id] => 17290961 [patent_doc_number] => 20210386800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROLOGICAL OR MENTAL DISORDERS COMPRISING EXTRACELLULAR VESICLES DERIVED FROM LACTOBACILLUS PARACASEI [patent_app_type] => utility [patent_app_number] => 17/343901 [patent_app_country] => US [patent_app_date] => 2021-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10043 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17343901 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/343901
Composition for prevention or treatment of neurological or mental disorders comprising extracellular vesicles derived from Jun 9, 2021 Issued
Array ( [id] => 20232763 [patent_doc_number] => 20250290082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-18 [patent_title] => FERMENTATION METHOD FOR PRODUCING MALONIC ACID [patent_app_type] => utility [patent_app_number] => 18/564939 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4741 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564939 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/564939
FERMENTATION METHOD FOR PRODUCING MALONIC ACID May 27, 2021 Pending
Array ( [id] => 17095456 [patent_doc_number] => 20210283247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => PROCESS FOR PREPARING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES [patent_app_type] => utility [patent_app_number] => 17/328657 [patent_app_country] => US [patent_app_date] => 2021-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328657 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/328657
PROCESS FOR PREPARING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES May 23, 2021 Abandoned
Array ( [id] => 18522969 [patent_doc_number] => 20230233620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => HIGH-COMPLEXITY SYNTHETIC GUT BACTERIAL COMMUNITIES [patent_app_type] => utility [patent_app_number] => 17/999516 [patent_app_country] => US [patent_app_date] => 2021-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 341 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999516 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999516
HIGH-COMPLEXITY SYNTHETIC GUT BACTERIAL COMMUNITIES May 20, 2021 Pending
Menu